Roche Holdings Ltd Sponsored ADR

Roche Holding AG's principle activities are divided into three divisions: Pharmaceuticals: prescription products and over the counter pharmaceutical products; Diagnostics: reagents and test kits for molecular and cell biology, analytical systems and reagents for clinical chemistry, immunochemistry, hematology and coagulation; Vitamins and fine chemicals: vitamin supplements for the animal feed, food, pharmaceuticals and cosmetics industries. A decision was taken to sell the vitamins and fine chemicals division to the DSM Group (The Netherlands) in August 2002, the sale should be complete during the first half of 2003. Pharmaceuticals accounted for 64% of 2002 revenues; diagnostics, 24% and vitamins and fine chemicals, 12%. The firm has no submitted 13F filings and does not appear to be an investment advisor.